CD19 and leukemia: C57BL/6 mice were injected with syngeneic leukemia cells expressing CD19, followed by treatment with untransduced (UTD) control T cells or murine CD19-targeting CAR T cells (mCART19), then given rhIL-7-hyFc (Fig. 4a).